Gestodiol

Quick links to important sections

Gestodiol

Method of action: Estrogenic

Treatment option: Dysmenorrhea, Cancer, Cancer,Prostate

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gestodiol

Property Description
Active Ingredients Gestodene, Ethinyl Estradiol (EE)
Form Tablet (Oral)
Pharmacological Class Sex hormones and modulators of the genital system; Hormonal contraceptives
General Use Prevention of pregnancy
Origin Synthetic steroid hormones

What Type of Medicine is Gestodiol?

Gestodiol is defined as a synthetic hormonal preparation administered orally in the form of a tablet, clinically recognized for its role as a combination oral contraceptive (COC). Its general function is the systemic prevention of pregnancy in women of reproductive age, representing a reliable method of birth control. It is situated within the broad pharmacological class of sex hormones and modulators of the genital system. This class of medicines works primarily by preventing the release of an egg from the ovary during the menstrual cycle. As a combination product, Gestodiol is distinguished by integrating two active ingredients, a strategy for enhanced contraceptive efficacy.

Composition: Ethinyl Estradiol and Gestodene

The formulation’s effectiveness stems from its two active ingredients: the estrogen compound Ethinyl Estradiol (EE) and the progestin compound Gestodene. Both are classified as synthetic steroid hormones. The efficacy of these combined hormonal contraceptives is well-established through years of clinical use. Gestodene is recognized as a third-generation progestin, which is a differentiating factor, as these compounds were developed to achieve potent hormonal activity with lower required doses compared to earlier generations. The combination is crucial for achieving the necessary physiological effects, which include ovulation suppression and key local changes within the reproductive tract to discourage conception.

Regulatory References

  1. Birth control pills: MedlinePlus Medical Encyclopedia
  2. Combined hormonal contraceptives | European Medicines Agency (EMA)

What side effects are possible with Gestodiol?

Gestodiol is a combination oral contraceptive and its safety profile, as documented by government regulatory bodies, centers on the inherent risks associated with hormonal preparations, particularly venous and arterial thromboembolic events (VTE/ATE).

Serious Adverse Reactions

The most serious documented safety concern is an increased risk of blood clots, including Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Stroke, and Myocardial Infarction (MI). The risk of VTE is higher in users of this type of combined hormonal contraceptive than in non-users. Other serious risks include the development of liver tumors (benign or malignant) and an increased risk of certain hormone-sensitive malignancies, such as breast cancer, which are linked to combination oral contraceptive use.

Common Adverse Reactions

Adverse reactions classified as Common (occurring in at least 1 out of every 100 users) often involve the Nervous, Gastrointestinal, and Reproductive systems. These include headache, nausea/vomiting, breast pain/tenderness, and mood changes.

Safety Restrictions and Monitoring

The medicine is contraindicated in women with a history of or active VTE/ATE, severe or multiple risk factors for thrombosis, severe hypertension, known or suspected hormone-sensitive malignancies, and liver disease. Patients with pre-existing conditions that may predispose them to hyperkalemia (high potassium levels) require specific monitoring due to the anti-mineralocorticoid activity of one of the active components.

Overdose and Emergency Response

The official regulatory documentation for Gestodiol, a combined oral contraceptive, defines its overdose profile as one of low acute toxicity. This classification indicates that the ingestion of multiple tablets is unlikely to result in life-threatening outcomes. The documented clinical manifestations associated with acute overdose primarily involve the gastrointestinal system, including symptoms such as nausea and vomiting. Effects on the reproductive tract are also listed, specifically withdrawal bleeding (vaginal bleeding) that may occur several days after the high-dose exposure, along with breast tenderness.

In all cases of suspected overdose, immediate medical assistance must be sought. Regulatory guidance mandates that you contact a Poison Control Center for specialized guidance, or proceed to seek medical help right away. Management is restricted to symptomatic and supportive treatment because no specific antidote is known to counteract the effects of the active ingredients. The procedural approach may require continuous monitoring of vital signs and potentially hospital observation to ensure clinical stabilization.

Therapeutic Uses of Gestodiol

What Gestodiol Treats: Main Uses and Benefits

The core therapeutic purpose of this medication is providing effective pregnancy prevention as a combination oral contraceptive. These medications are also commonly used to help with menstrual-related disorders and other health contexts. Gestodiol is generally applied across conditions characterized by periods of heightened symptoms linked to hormonal fluctuations.


Menstrual, Skin, and Preventative Support

The primary therapeutic application is systemic birth control and supportive cycle control. Beyond contraception, Gestodiol is commonly used to help with managing severe menstrual cramping (dysmenorrhea), excessive bleeding (menorrhagia), persistent acne, and hirsutism. It is also applied in situations where patients experience severe, cyclical premenstrual distress (PMDD), and may assist with a reduction in the risk of ovarian and endometrial cancers.


Core Therapeutic Benefits

Quick Fact: Relief for Menstrual and Hormonal Discomfort The medication helps ease symptoms related to physical discomfort and may support patients in addressing the functional strain caused by heavy bleeding and severe pain.

By assisting with the management of symptom intensity, Gestodiol may contribute to improved comfort during symptomatic periods. Its application in these contexts may assist with maintaining functional stability, which can help improve day-to-day comfort. The medication is considered relevant for easing distress related to symptomatic manifestations of conditions like PCOS and endometriosis as part of comprehensive management.

Regulatory References

  1. NIH MedlinePlus overview of oral contraceptives

Eligibility and Restrictions for Use

Gestodiol is indicated for use by females of reproductive potential for the prevention of pregnancy. However, its use is strictly governed by medical criteria documented in regulatory labeling (e.g., FDA, EMA). The following conditions define who must not use the medicine:

  • Absolute Contraindications: Females with a high risk of arterial or venous thrombotic diseases, including a history of DVT, PE, stroke, or known hypercoagulopathies, are prohibited from use. This also applies to women over age 35 who smoke and those with uncontrolled hypertension.
  • Organ/Oncology Status: Use is contraindicated in patients with current or history of liver tumors or severe hepatic disease, or any diagnosis of breast cancer or other hormone-sensitive malignancy.
  • Neurological/Hepatitis: Women with migraine with focal neurological symptoms or aura, and those taking certain Hepatitis C drug combinations are also prohibited from using Gestodiol.

Conditional or Restricted Use

Status Regulatory Rule (Examples)
Pregnancy Contraindicated (Must be discontinued if pregnancy is confirmed).
Lactation Not recommended (May decrease milk production).
Postpartum/Surgery Must not be started until at least 4 weeks postpartum or 4 weeks prior to/2 weeks after major surgery involving immobilization.

Use is not applicable for the pediatric population (pre-menarche) or geriatric population (post-reproductive age).

What should I know about interactions with other medicines?

Gestodiol’s interaction profile is structured around substances that modify the exposure of its active components or that are officially prohibited for co-administration.

Medicinal Product and Substance Interactions

Co-administration with potent hepatic enzyme-inducing drugs (e.g., Rifampicin, Griseofulvin, and the herbal product St. John's Wort) is documented to decrease the plasma concentrations of the active ingredients. This metabolic interaction may lead to reduced contraceptive efficacy. Conversely, Gestodiol is recognized as an inhibitor of Cytochrome P450 1A2 (CYP1A2), resulting in a documented increase in the plasma levels and effects of co-administered substrates, such as Tizanidine and Caffeine.

Regulatory Restrictions and Conditions

A formal contraindication exists for co-administration with specific Hepatitis C virus (HCV) drug regimens, including combinations containing ombitasvir, paritaprevir/ritonavir, or dasabuvir, due to the established risk of severe liver enzyme elevation (ALT). Another major regulatory restriction is the prohibition of use in women over 35 who smoke, which is due to a significantly heightened risk of cardiovascular events, including venous thromboembolism. Procedurally, if severe gastrointestinal upset (vomiting or severe diarrhea) occurs within three to four hours of tablet intake, the regulatory protocol for a missed dose must be followed. Use must also be discontinued at least four weeks before major elective surgery due to the increased vascular risk associated with prolonged immobilization.

Mechanism of Action

Gestodiol is a combination hormonal product containing gestodene, a synthetic progestogen, and ethinylestradiol, a synthetic estrogen.

The pharmacodynamic mechanism is mediated by both components, primarily targeting the hypothalamic-pituitary-ovarian (HPO) axis and reproductive tract tissues.

Gestodene functions as a progesterone receptor (PR) agonist, exhibiting high binding affinity for its intracellular receptor located in target tissues like the hypothalamus, pituitary gland, cervix, and endometrium. Agonism of the PR exerts a potent negative feedback effect on the hypothalamus, inhibiting the pulsatile release of gonadotropin-releasing hormone (GnRH). This downstream effect reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. The suppression of the mid-cycle LH surge prevents the rupture of the mature follicle, leading to a state of anovulation.

Additionally, gestodene modulates the cervical mucus, increasing its viscosity and reducing its penetrability to sperm. Within the endometrium, it induces glandular atrophy and stromal decidualization, resulting in a lining that is rendered non-receptive.

Ethinylestradiol acts as an estrogen receptor (ER) agonist, potentiating the suppression of FSH secretion and contributing to the stabilization of the endometrial lining.

Dosage and Administration Information

How to Use Gestodiol

The usage of Gestodiol (Gestodene/Ethinyl Estradiol) is defined by a non-titratable, cyclic regimen consistent with its role as a combination oral contraceptive. Administration is strictly via the oral route as a fixed-dose tablet. The primary principle is continuous daily intake, following a 28-day schedule.


Official Administration Schedule

The standard regimen requires taking one tablet once daily at approximately the same time every day to maintain consistent hormone levels. While the tablet may be taken without regard to meals, timing consistency is a prescriptive requirement for effective use.

Administration Component Official Instruction
Route Oral (by mouth) only
Frequency Once daily, at the same time each day
Regimen 28-day cycle following sequence on the blister pack
Dose One tablet daily (fixed combination strength)

Procedural Requirements

Gestodiol is administered in a sequential pattern, meaning the tablets must be taken in the specific order indicated on the blister packaging. A typical 28-day cycle consists of active hormone tablets followed by a brief period of inactive tablets. When the last tablet of one cycle is finished, the next 28-day cycle must begin immediately.

Specific detailed protocols must be followed in the event of a missed active tablet. These protocols vary depending on when the dose was missed and how many doses were missed, and may involve using a backup non-hormonal method of contraception. In post-pubertal adolescents, the dosing follows the same daily adult regimen.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Combination Therapy: Drug A + Drug B

Studies have explored whether using Drug A and Drug B together, often referred to as combination therapy, was associated with certain measured changes.

  • Symptom Changes: Studies evaluated whether combining Drug A with Drug B was associated with an effect on symptoms. Findings in these trials were mixed, with some showing an association with symptom changes and others showing no clear difference when compared to placebo.
  • Tolerability: One randomized trial examined the tolerability of this combination. Data on Drug C also exists, though studies have not directly compared its associated changes with those of Drug A plus Drug B.
  • Quality of Life: Several studies explored whether the combination was associated with an improvement in the quality of life score. These studies typically involved surveys asking participants about their overall well-being.

Drug A as Monotherapy

Research has also focused on findings associated with Drug A when used alone (monotherapy).

  • Pain Score Evaluation: Research evaluated whether the use of Drug A was associated with changes in reported pain scores at the one-week mark. Further research is needed to understand the long-term findings associated with monotherapy with Drug A.
  • Safety Profile: Trials focused on the general adult population to evaluate the safety profile of Drug A monotherapy.

Drug B as Monotherapy

Research examined whether the use of Drug B was associated with changes in related symptoms, including studies exploring low doses.

  • Symptom Management: Findings varied across different studies that evaluated the overall association of this treatment with measured endpoints. Some research focused on participants with mild symptoms to evaluate the treatment’s effect in that subgroup.
  • Adverse Effects: Research explored potential adverse events, noting that the most commonly reported were mild and transient, such as temporary nausea. Research continues to explore whether Drug B use is associated with an individual’s long-term reliance on pain management.

Frequently Asked Questions (FAQ)

Common questions about Gestodiol (FAQ)


Q: How long does Gestodiol typically take to start working?

According to official product information, contraceptive efficacy is typically established after taking the active tablets for 7 consecutive days. This timeframe aligns with the regulatory requirement to consider backup contraception when initiating treatment or restarting after a prolonged break.


Q: Can Gestodiol make you gain weight?

Weight gain is a reported adverse event in clinical trials for this type of medication. However, regulatory reviews often indicate that definitive medical evidence has not fully established a causal link between combination oral contraceptives and weight changes.


Q: Can I have a glass of wine or alcohol while taking Gestodiol?

Regulatory guidance suggests a minor interaction may exist between the active ingredients and alcohol. This potential interaction points to a possible increase in the central nervous system effects and blood levels of alcohol, though the corresponding data can be contradictory.


Q: Does Gestodiol interact with over-the-counter cold or flu medicines?

Official drug interaction information indicates that certain common medications can affect the drug's effectiveness. Specifically, substances like acetaminophen (paracetamol) and some broad-spectrum antibiotics have been documented to potentially alter Gestodiol's levels or its intended efficacy in the body.


Q: What are the signs of a serious side effect from Gestodiol?

Patient information describes key symptoms that may signal a serious adverse reaction, particularly blood clots. These warning signs include swelling and pain in one leg, sudden breathlessness or severe chest pain, and sudden weakness or a prolonged, severe headache.


Q: Can Gestodiol be used by people of all age groups, like teenagers?

Yes, Gestodiol is indicated for use by females of reproductive potential. Official regulatory documents confirm that this includes teenage females who have already begun menstruation (post-menarche). Use is designated only for those who are post-menarche.


Q: Can Gestodiol make you feel dizzy or lightheaded?

Dizziness or lightheadedness is not generally listed as a common adverse reaction for Gestodiol. However, severe lightheadedness or dizziness is noted in patient safety information as a potential symptom of a very serious, though rare, complication, such as a blood clot in the lungs.


Q: Does Gestodiol affect my ability to drive or operate machinery?

Regulatory documents for this class of oral contraceptive generally state that the drug is expected to have no or negligible influence on a person's ability to drive or use machinery. This indicates that the labels do not report effects that would significantly impair these abilities.


Q: Is it possible to develop an allergy to Gestodiol?

Yes, as with most medicines, it is possible to develop hypersensitivity or allergic reactions to the active components or the non-active ingredients. Signs that may point to an allergic reaction include itching, a rash, or localized swelling.


Q: Can Gestodiol be crushed, split, or chewed?

Gestodiol is provided as a fixed-dose tablet intended only for the oral route. Because the tablet does not have a score line, the design indicates that the tablet should be swallowed whole to ensure the intended dose is delivered correctly.


Q: Is Gestodiol the generic name, or is a generic version available?

The drug product is a specific brand name formulation. The active ingredients are Gestodene and Ethinyl Estradiol, which are the generic chemical compounds that provide the intended therapeutic effect.


Q: Can Gestodiol cause vision changes or blurry sight?

Sudden vision changes are listed as a potential symptom of a serious complication that requires immediate medical attention. Official warnings include sudden, partial, or complete loss of vision, or other visual disturbances, which may indicate a blood clot in the eye.


Q: What are the boxed warnings or special cautions listed for Gestodiol?

The most prominent special caution in official labeling relates to the contraindication against use in women over age 35 who smoke. This restriction is included because the combination is associated with a significantly heightened risk of serious cardiovascular events, including dangerous blood clots.


Q: Is it normal to have a slight headache when starting Gestodiol?

Headache is listed in official adverse reaction data as a common side effect of Gestodiol, often occurring in at least 1 out of every 100 users. It is frequently reported when people first start taking this type of medication.

How should Gestodiol be stored and disposed of?

How to Store and Dispose of Gestodiol?

Gestodiol (Gestodene/Ethinyl Estradiol) must be stored in accordance with official labeling requirements to preserve the medicine's stability and efficacy.

Storage Conditions

Requirement Instructions
Temperature Store below 25 C (77 F); do not refrigerate or freeze.
Protection Must be protected from both light and moisture.
Packaging Keep the tablets in the original blister pack and outer carton until use.
Child Safety Store out of the sight and reach of children.

Disposal Instructions

Unused or expired Gestodiol must not be disposed of using general household trash or by flushing it down the toilet (wastewater). Disposal must strictly follow local requirements for the proper discarding of pharmaceutical products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gestodiol found in:

A-Z Index: